Results 131 to 140 of about 415,892 (262)
An assessment of medication errors and associated factors to strengthen patient safety practices in a tertiary hospital in Cameroon. [PDF]
Signang AN +3 more
europepmc +1 more source
ABSTRACT Objective Blood biomarkers are increasingly critical for non‐invasive Alzheimer's Disease (AD) diagnostics and research but typically require on‐site processing. Remote point‐of‐care collection methods could enhance biomarker testing in clinical and research settings.
Sara Ho +9 more
wiley +1 more source
Evaluation of the Medication Never Events and Related Factors: A Nationwide Database Study. [PDF]
Isfahani MN +4 more
europepmc +1 more source
Adverse drug reactions and drug errors [PDF]
openaire +1 more source
Association Between Neurofilament Light Chain and Real‐World Ambulatory Function in Progressive MS
ABSTRACT Objective Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in multiple sclerosis (MS), yet associations with functional outcomes remain unclear. Longitudinal associations between serum NfL (sNfL) and daily step count (STEPS) from wearable devices were assessed in a large international progressive MS cohort.
Gabby B. Joseph +5 more
wiley +1 more source
e-Harvis and detection of IV incompatibilities. [PDF]
Catania PN.
europepmc +1 more source
Errors and Misconceptions in Drug Prescribing
openaire +2 more sources
Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact
ABSTRACT Objective To examine the relationship of subjective cognitive concerns (SCC) with biomarkers of Alzheimer's disease (AD), neurodegeneration, and Parkinson's disease (PD) and domain‐specific cognitive trajectories among cognitively unimpaired persons with de novo PD. Method Cognitively unimpaired participants with SCC (n = 294) and without SCC (
Francesca V. Lopez +5 more
wiley +1 more source
Enhancing Pediatric Pharmaceutical Care: Development and Evaluation of a Rectal Demonstration Model for Pediatric Patients with Inflammatory Bowel Diseases. [PDF]
Ruschkowski M +5 more
europepmc +1 more source

